• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [24124 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2022     Agency for Care Effectiveness (ACE) Sitagliptin for treating type 2 diabetes mellitus
2022     Agency for Care Effectiveness (ACE) Sitagliptin for treating type 2 diabetes mellitus
2011     Institute for Clinical Evaluative Sciences (ICES) Site-specific rates of shock, therapy and death after ICD implantation in Ontario: report from the Ontario ICD database
2000     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) Situation and approaches to waiting lists in Europe
2021     Medical Services Advisory Committee (MSAC) Six genetic tests for the diagnosis of inheritable cardiac conduction disorders
2020     NIHR Health Technology Assessment programme Six versus 12 months' adjuvant trastuzumab in patients with HER2-positive early breast cancer: the PERSEPHONE non-inferiority RCT
2019     NIHR Health Technology Assessment programme Sixteen-week versus standard eight-week prednisolone therapy for childhood nephrotic syndrome: the PREDNOS RCT
2009     Norwegian Knowledge Centre for the Health Services (NOKC) Skills laboratories: virtual training of manual and practical skills
2007     Penn Medicine Center for Evidence-based Practice (CEP) Skin antiseptics to prevent surgical site infections
2012     HAYES, Inc. Skin autofluorescence to aid in assessment or prediction of diabetes-related complications
2007     Adelaide Health Technology Assessment (AHTA) Skin biopsy diagnosis of peripheral neuropathy
2008     HAYES, Inc. Skin cholesterol test using the PREVU* point of care (POC) skin sterol test (PreMD Inc.) for prediction of coronary artery disease risk
2021     Ontario Health Skin substitutes for adults with diabetic foot ulcers and venous leg ulcers
2008     Penn Medicine Center for Evidence-based Practice (CEP) Skin substitutes for surgical wound repair
2013     Agency for Healthcare Research and Quality (AHRQ) Skin substitutes for treating chronic wounds
2012     Agency for Healthcare Research and Quality (AHRQ) Skin substitutes for treating chronic wounds
2016     Health Quality Ontario (HQO) Skin testing for allergic rhinitis: a health technology assessment
2016     Health Quality Ontario (HQO) Skin testing for allergic rhinitis: OHTAC recommendation
2000     HAYES, Inc. Sleep apnea diagnosis, pediatric
1996     Comite d'Evaluation et de Diffusion des Innovations Technologiques (CEDIT) Sleep apnea syndrome (V): telemedicine in the management of sleep apnea syndrome - systematic review, expert panel
1999     Comite d'Evaluation et de Diffusion des Innovations Technologiques (CEDIT) Sleep apnea syndrome: polysomnography in preterm infant (systematic review, primary research, expert panel)
2005     HAYES, Inc. Sleep apnea treatment, surgical
2005     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Sleep laboratory investigations: a review of patient referral guidelines
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Sleep medications for adults diagnosed with insomnia: clinical evidence and harms
2022     National Institute for Health and Care Excellence (NICE) Sleepio to treat insomnia and insomnia symptoms. NICE medical technologies guidance 70
2008     Adelaide Health Technology Assessment (AHTA) SleepStrip for diagnosis of obstructive sleep apnoea
2008     Haute Autorite de sante (HAS) Sleeve gastrectomy
2007     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Sleeve gastrectomy as a single stage bariatric procedure
2017     Agenzia nazionale per i servizi sanitari regionali (Agenas) Sling operation for urinary incontinence in women and men
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Slow-release opioids for postoperative pain: clinical effectiveness
2022     National Institute for Health and Care Excellence (NICE) Slow-release potassium bicarbonate-potassium citrate for treating distal renal tubular acidosis (terminated appraisal). NICE technology appraisal guidance 838
2023     Austrian Institute for Health Technology Assessment (AIHTA) SMA therapies: mid- to long-term follow-up of spinal muscular atrophy (SMA) patients treated for ≥24 months with nusinersen or onasemnogene abeparvovec and ≥12 months for patients treated with risdiplam or combination therapies
2003     Medical Advisory Secretariat (MAS) Small bowel transplant: an evidence-based analysis
2001     HAYES, Inc. Small bowel transplantation
2000     Agency for Healthcare Research and Quality (AHRQ) Small bowel transplantation
2005     HAYES, Inc. Small bowel, small bowel-liver, and multivisceral transplantation
2022     Adelaide Health Technology Assessment (AHTA) Small gene panel testing for non-small cell lung carcinoma
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Smart infusion pump use in hospitalized patients: clinical safety and guidelines
2013     NIHR Horizon Scanning Centre (NIHR HSC) Smart-Glasses depth-based visual aids for the partially sighted
2006     NIHR Horizon Scanning Centre (NIHR HSC) Smartinhaler for personal asthma management: horizon scanning technology briefing
2007     Adelaide Health Technology Assessment (AHTA) Smartinhaler™ with audiovisual reminder for asthma medication
2010     HAYES, Inc. SmartPill GI monitoring system (SmartPill Corp.) for diagnosis of gastroparesis and monitoring of intestinal motility
2013     NIHR Horizon Scanning Centre (NIHR HSC) SmartSensor electronic oral glucose tolerance test for screening for diabetes
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) SmartSite bag access device: safety
2022     Finnish Coordinating Center for Health Technology Assessment (FinCCHTA) Smila Care Service
2009     Penn Medicine Center for Evidence-based Practice (CEP) Smoking cessation for inpatients
2012     Medical Advisory Secretariat (MAS) Smoking cessation for patients with chronic obstructive pulmonary disease (COPD): an evidence-based analysis
2014     HAYES, Inc. Smoking cessation in patients with schizophrenia
2015     NIHR Health Technology Assessment programme Smoking Cessation Intervention for severe Mental Ill Health Trial (SCIMITAR): a pilot randomised control trial of the clinical effectiveness and cost-effectiveness of a bespoke smoking cessation service
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Smoking cessation interventions for pregnant women and mothers of infants: a review of the clinical effectiveness, safety, and guidelines
2004     Danish Institute for Health Services Research (DSI) Smoking cessation interventions in pharmacies. Demand from smokers and the ability of general practitioners to recruit participants
2014     Agency for Healthcare Research and Quality (AHRQ) Smoking cessation interventions in pregnancy and postpartum care
2021     NIHR Health Technology Assessment programme Smoking cessation medicines and e-cigarettes: a systematic review, network meta-analysis and cost-effectiveness analysis
2021     NIHR Health Technology Assessment programme Smoking cessation medicines and e-cigarettes: a systematic review, network meta-analysis and cost-effectiveness analysis
1998     The Swedish Council on Health Technology Assessment (SBU) Smoking cessation methods
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Smoking cessation prior to surgery: clinical evidence
2001     University HealthSystem Consortium (UHC) Smoking cessation therapies
1998     University of York Smoking cessation: what the health service can do
2011     HAYES, Inc. SNaP wound care system (Spiracur Inc.) for treatment of lower extremity ulcers
2012     HAYES, Inc. SNaP wound care system (Spiracur Inc.) for treatment of lower extremity ulcers
2001     Institute of Technology Assessment (ITA) Social implications of the increasing spread of technology in medicine
2008     Medical Advisory Secretariat (MAS) Social isolation in community-dwelling seniors: an evidence-based analysis
2014     Penn Medicine Center for Evidence-based Practice (CEP) Social media, text messaging, and post-discharge communication
2020     NIHR Health Services and Delivery Research programme Social norms interventions to change clinical behaviour in health workers: a systematic review and meta-analysis
2021     NIHR Health Technology Assessment programme Social recovery therapy for young people with emerging severe mental illness: the Prodigy RCT
2017     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Social return on investment: outcomes, methods, and economic parameters
2011     HAYES, Inc. Social skills training for autistic spectrum disorders
2016     NIHR Health Technology Assessment programme Social Stories to alleviate challenging behaviour and social difficulties exhibited by children with autism spectrum disorder in mainstream schools: design of a manualised training toolkit and feasibility study for a cluster randomised controlled trial with nested qualitative and cost-effectiveness components
2016     Penn Medicine Center for Evidence-based Practice (CEP) Social work support following distress screening in oncology care
2003     Center for Medical Technology Assessment (CMT) Societal costs of rheumatic diseases
2018     Agency for Healthcare Research and Quality (AHRQ) Sodium and potassium intake: effects on chronic disease outcomes and risks
2020     NIHR Health Technology Assessment programme Sodium bicarbonate to improve physical function in patients over 60 years with advanced chronic kidney disease: the BiCARB RCT
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Sodium chloride inhalation for the treatment of cystic fibrosis: a review of the clinical evidence, cost-effectiveness and guidelines
2009     HAYES, Inc. Sodium hyaluronate for osteoarthritis
2004     HAYES, Inc. Sodium hyaluronate for osteoarthritis
2004     NIHR Horizon Scanning Centre (NIHR HSC) Sodium oxybate (Xyrem) for cataplexy and excessive daytime sleepiness in narcolepsy - horizon scanning review
2009     NIHR Horizon Scanning Centre (NIHR HSC) Sodium oxybate (Xyrem) for fibromyalgia - first line
2013     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Sodium phenylbutyrate (Pheburane®)
2015     Health Quality Ontario (HQO) Sodium restriction in heart failure: a rapid review
2015     NIHR Horizon Scanning Centre (NIHR HSC) Sodium thiosulfate for prevention of hearing loss in children receiving cisplatin chemotherapy
2011     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Sodium valproate (Episenta®)
2015     NIHR Horizon Scanning Centre (NIHR HSC) Sodium zirconium cyclosilicate for hyperkalaemia – first line
2022     Agency for Care Effectiveness (ACE) Sodium zirconium cyclosilicate for treating hyperkalaemia
2019     National Institute for Health and Care Excellence (NICE) Sodium zirconium cyclosilicate for treating hyperkalaemia. NICE technology appraisal guidance 599
2020     Agency for Care Effectiveness (ACE) Sodium-glucose co-transporter 2 (SGLT2) inhibitors for type 2 diabetes mellitus
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Sofosbuvir (Sovaldi — Gilead Sciences Canada, Inc.) indication: chronic hepatitis C infection
2015     NIHR Horizon Scanning Centre (NIHR HSC) Sofosbuvir (Sovaldi) with GS-5816 for chronic hepatitis C
2012     NIHR Horizon Scanning Centre (NIHR HSC) Sofosbuvir for chronic hepatitis C infection with compensated liver disease
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Sofosbuvir for the treatment of patients with genotype 4 hepatitis C: a review of the clinical efficacy, cost-effectiveness, and guidelines
2014     NIHR Health Technology Assessment programme Sofosbuvir for treating chronic hepatitis C
2015     National Institute for Health and Care Excellence (NICE) Sofosbuvir for treating chronic hepatitis C. NICE technology appraisal guidance 330
2013     NIHR Horizon Scanning Centre (NIHR HSC) Sofosbuvir with ledipasvir for hepatitis C, genotype 1
2016     HAYES, Inc. Sofosbuvir-velpatasvir for chronic HCV infection
2017     National Institute for Health and Care Excellence (NICE) Sofosbuvir-velpatasvir for treating chronic hepatitis C. NICE technology appraisal guidance 430
2018     National Institute for Health and Care Excellence (NICE) Sofosbuvir–velpatasvir–voxilaprevir for treating chronic hepatitis C. NICE technology appraisal guidance 507
2016     NIHR Horizon Scanning Centre (NIHR HSC) Sofosbuvir, GS-9857 and velpatasvir triple therapy for chronic hepatitis C
2006     Institute for Clinical Effectiveness and Health Policy (IECS) Soft tissue augmentation for HIV patients with lipodystrophy syndrome
2007     National Institute for Health and Care Excellence (NICE) Soft-palate implants for obstructive sleep apnoea. NICE interventional procedures guidance 241
2007     National Institute for Health and Care Excellence (NICE) Soft-palate implants for simple snoring. NICE interventional procedures guidance 240
2014     NIHR Horizon Scanning Centre (NIHR HSC) SoftVue™ system for diagnostic breast imaging